Correlation between duration of first-line treatment with daratumumab, lenalidomide, and dexamethasone and overall survival in patients with transplant-ineligible multiple myeloma in Japan

Correlation between duration of first-line treatment with daratumumab, lenalidomide, and dexamethasone and overall survival in patients with transplant-ineligible multiple myeloma in Japan

<p>Optimal management of multiple myeloma (MM) remains challenging, particularly among patients with transplant-ineligible newly diagnosed MM (TIE NDMM). Daratumumab + lenalidomide + dexamethasone (DRd) is approved in Japan for the treatment of TIE NDMM. A previously reported real-world, retro...

保存先:

書誌詳細
第一著者:	Kazuhito Suzuki (22688384) (author)
その他の著者:	Miku Ito (22688387) (author), Chika Sakai (5712761) (author), Hiroaki Tsuchiya (2437369) (author), David Bin-Chia Wu (7251623) (author), Yosuke Koroki (12979839) (author)
出版事項:	2025
主題:	Medicine Pharmacology Biotechnology Immunology Cancer Science Policy Mental Health Daratumumab duration of treatment lenalidomide newly diagnosed multiple myeloma overall survival real-world evidence
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料

Table 1_Comparison of self-reported sleep sufficiency and accelerometer-measured sleep duration in relation to mental health, physical health, and life satisfaction.docx
著者:: Hannah Ahrensberg (22686239)
出版事項: (2025)

Table 1_Clinical study on the effects of different cold compress methods and durations on postoperative complications following mandibular impacted third molar extraction.docx
著者:: Zhiwen Xie (6335777)
出版事項: (2025)

Data Sheet 1_Impact of individualized and structured aerobic exercise on clinical outcomes in pediatric congenital heart diseases with post-surgical rehabilitation: a meta-analysis.docx
著者:: Ayoola Awosika (22687004)
出版事項: (2025)

DENV and CHIKV IgG serology and RT-PCR test results among overall study population and individual study sites Ukunda and Kisumu, Kenya, Dec 2019–Feb 2022.
著者:: Bethel Alebel Bayrau (22676588)
出版事項: (2025)

Overall acceptability of the MNH-EPI-COS.
著者:: Karen Klein (6650600)
出版事項: (2025)

The MBM-Index as an independent predictor of overall survival (OS) in melanoma.
著者:: Jingxin Zeng (18773484)
出版事項: (2025)

Participant characteristics in the overall cohort and in groups classified by dysmenorrhea score.
著者:: Maika Nariai (22676447)
出版事項: (2025)

Supplementary Table S1 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma
著者:: Phyllis S.Y. Chong (17141520)
出版事項: (2025)

Supplementary Table S2 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma
著者:: Phyllis S.Y. Chong (17141520)
出版事項: (2025)

Kaplan-Meier curves of (A) progression-free survival and (B) overall survival.
著者:: Lu Xie (20428615)
出版事項: (2025)

Reducing Anxiety and Improving Adherence in Kidney Transplant Recipients: A Cognitive Behavioral Intervention -Based Approach
著者:: Chao Zhong (22679885)
出版事項: (2025)

Short periods of increased connectivity between ROIs are characterized by a sparse overall network state.
著者:: Adam J. O. Dede (11554007)
出版事項: (2025)

Data Sheet 1_Glycocalyx kinetics and injury during liver procurement and transplantation as predictors of early graft dysfunction.docx
著者:: Nassiba Beghdadi (9577919)
出版事項: (2025)

Additional file 3 of Trends in national-level school feeding policy objectives worldwide: Japan and multiple countries
著者:: Takeshi Akiyama (4825470)
出版事項: (2025)

Additional file 2 of Trends in national-level school feeding policy objectives worldwide: Japan and multiple countries
著者:: Takeshi Akiyama (4825470)
出版事項: (2025)

Presynaptic and postsynaptic weights change monotonically linearly over stimulus duration.
著者:: Nicholas Hananeia (22683665)
出版事項: (2025)

A linear regression analysis was conducted between the overall performance in the visual selective attention task (accuracy and reaction time) and the CISS score.
著者:: Mohammed M. Alnawmasi (11156577)
出版事項: (2025)

Investigation on the Occurrence of Premature Ovarian Insufficiency after Allogeneic Haematopoietic Stem Cell Transplantation and Prognosis Analysis - a single-center real-world cross-sectional study
著者:: 辰宇石 (22420348)
出版事項: (2025)

Hematocrit levels.
著者:: Ömer Yusuf İpek (22676357)
出版事項: (2025)

Morris water maze spatial patterns.
著者:: Ömer Yusuf İpek (22676357)
出版事項: (2025)

Morris water maze swim paths.
著者:: Ömer Yusuf İpek (22676357)
出版事項: (2025)

Morris water maze performance during the probe trial (Day 5).
著者:: Ömer Yusuf İpek (22676357)
出版事項: (2025)

Morris water maze performance across acquisition and reversal phases.
著者:: Ömer Yusuf İpek (22676357)
出版事項: (2025)

Three-chamber test spatial patterns.
著者:: Ömer Yusuf İpek (22676357)
出版事項: (2025)

Three-chamber test behavioral outcomes.
著者:: Ömer Yusuf İpek (22676357)
出版事項: (2025)

Experimental design.
著者:: Ömer Yusuf İpek (22676357)
出版事項: (2025)

Hematological parameters statistical data.
著者:: Ömer Yusuf İpek (22676357)
出版事項: (2025)

Morris water maze test day based statistical data.
著者:: Ömer Yusuf İpek (22676357)
出版事項: (2025)

Morris water maze test progression statistical data.
著者:: Ömer Yusuf İpek (22676357)
出版事項: (2025)

Three chamber test statistical data.
著者:: Ömer Yusuf İpek (22676357)
出版事項: (2025)

Multivariate analysis between DENV and CHIKV seroconversion and selected risk factors.
著者:: Bethel Alebel Bayrau (22676588)
出版事項: (2025)

Univariate analysis between DENV and CHIKV seroconversion and selected risk factors.
著者:: Bethel Alebel Bayrau (22676588)
出版事項: (2025)

Multivariate analysis between DENV and CHIKV seropositivity and selected risk factors.
著者:: Bethel Alebel Bayrau (22676588)
出版事項: (2025)

Univariate analysis between DENV and CHIKV seropositivity and selected risk factors.
著者:: Bethel Alebel Bayrau (22676588)
出版事項: (2025)

Descriptive statistics and demographics of study participants, Ukunda and Kisumu sites, Kenya, Dec 2019–Feb 2022.
著者:: Bethel Alebel Bayrau (22676588)
出版事項: (2025)

Kaplan Meier survival curves for new DENV seropositivity during the 2-year study period from Dec 2019 – Feb 2022..
著者:: Bethel Alebel Bayrau (22676588)
出版事項: (2025)

Kaplan Meier survival curves for new CHIKV seropositivity during the 2- year study period from Dec 2019 – Feb 2022.
著者:: Bethel Alebel Bayrau (22676588)
出版事項: (2025)

Distribution of DENV and CHIKV seroprevalence by age group of participants in the study.
著者:: Bethel Alebel Bayrau (22676588)
出版事項: (2025)

Seroconversion of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022.
著者:: Bethel Alebel Bayrau (22676588)
出版事項: (2025)

Seroprevalence of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022.
著者:: Bethel Alebel Bayrau (22676588)
出版事項: (2025)

Cannot write session to /tmp/vufind_sessions/sess_o8a3st69ij71bsaskbacaj43so